Form 4: Herbalife Director Sophie L'Helias Receives Equity Grant

Herbalife Ltd. director Sophie L'Helias has been granted 11,879 restricted stock units as part of the company's 2023 Stock Incentive Plan.

Summary

• Director Sophie L'Helias was granted 11,879 restricted stock units (RSUs) on May 8, 2026.
• The RSUs were issued at a price of $0.00 as part of director compensation.
• Following this transaction, L'Helias's total beneficial ownership in the company increased to 78,682 shares.
• The grant is subject to a vesting period, with 100% of the units scheduled to vest on April 15, 2027.
• Vesting is contingent upon the director's continued service on the Board of Directors through the vesting date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event. While insider ownership is generally positive, this is a scheduled compensation grant rather than a proactive market purchase.

Positives

• Increased insider ownership by the director to a total of 78,682 shares.
• Alignment of director interests with shareholders through equity-based compensation.
• The grant includes a one-year vesting cliff, encouraging retention and long-term oversight.

Negatives

• The acquisition does not represent an open-market purchase with the director's own capital.
• Potential for minor future dilution when the restricted stock units vest and convert to common stock.

Risks

• The value of the grant is subject to market fluctuations of Herbalife Ltd. (HLF) stock price until the vesting date in 2027.
• The director must remain in service until April 15, 2027, or the units will be forfeited.

Future Outlook

The reporting person is expected to vest in the full amount of 11,879 shares on April 15, 2027, assuming continued service on the Board of Directors.

Management Comments

• The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date.

Industry Context

StockSavvy.ai notes that this filing reflects standard corporate governance practices within the health and wellness industry, where equity grants are used to attract and retain experienced board members while aligning their incentives with those of the shareholders.

Comparison to Industry Standards

• The grant size is consistent with annual equity awards for directors of mid-cap consumer goods companies.
• The one-year vesting cliff is a standard benchmark for director compensation to ensure focus on annual performance cycles.
• Herbalife's use of the Amended and Restated 2023 Stock Incentive Plan aligns with modern institutional investor preferences for structured equity compensation.

Corporate Governance

Related Party Transactions

• The issuance of 11,879 RSUs to Director Sophie L'Helias as part of her compensation package.

Stakeholder Impact

• Shareholders: Provides assurance that board members have a vested interest in the company's share price performance.
• Management: Ensures continuity of board oversight through the 2027 vesting period.

Next Steps

• Vesting of 11,879 RSUs on April 15, 2027.

Key Dates

Recommendation

This filing represents a routine compensation event for a director and does not provide new material information regarding the company's operational performance or strategic shift that would warrant a change in investment thesis.

Keywords

Herbalife Ltd., HLF, Insider Trading, Form 4, Sophie L'Helias, Restricted Stock Units, Director Compensation, Equity Incentive Plan